Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Hovorka, R; Chassin, LJ; Wilinska, ME; Canonico, V; Akwi, JA; Federici, MO; Massi-Benedetti, M; Hutzli, I; Zaugg, C; Kaufmann, H; Both, M; Vering, T; Schaller, HC; Schaupp, L; Bodenlenz, M; Pieber, TR.
Closing the loop: the adicol experience.
Diabetes Technol Ther. 2004; 6(3): 307-318.
Doi: 10.1089/152091504774197990
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
-
Pieber Thomas
-
Schaupp Lukas
-
Weiss Manfred
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- The objective of the project Advanced Insulin Infusion using a Control Loop (ADICOL) was to develop a treatment system that continuously measures and controls the glucose concentration in subjects with type 1 diabetes. The modular concept of the ADICOL's extracorporeal artificial pancreas consisted of a minimally invasive subcutaneous glucose system, a handheld PocketPC computer, and an insulin pump (D-Tron, Disetronic, Burgdorf, Switzerland) delivering subcutaneously insulin lispro. The present paper describes a subset of ADICOL activities focusing on the development of a glucose controller for semi-closed-loop control, an in silico testing environment, clinical testing, and system integration. An incremental approach was adopted to evaluate experimentally a model predictive glucose controller. A feasibility study was followed by efficacy studies of increasing complexity. The ADICOL project demonstrated feasibility of a semi-closed-loop glucose control during fasting and fed conditions with a wearable, modular extracorporeal artificial pancreas.
- Find related publications in this database (using NLM MeSH Indexing)
-
Blood Glucose - analysis
-
Diabetes Mellitus, Type 1 - blood
-
Equipment Design - blood
-
Humans - blood
-
Insulin Infusion Systems - blood
-
Monitoring, Ambulatory - instrumentation